This inventor holds 1 USPTO granted patent. Top assignees: Cytokinetics, Inc., Smithkline Beecham Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2007
Title: Celebrating the Innovations of George Yiannikourous
Introduction
George Yiannikourous is an accomplished inventor based in Florence, South Carolina, known for his significant contribution to the field of medicinal chemistry. With one patent to his name, he stands out for his innovative approach to synthesizing complex compounds that may lead to advancements in pharmaceuticals.
Latest Patents
Yiannikourous holds a patent titled "Syntheses of Quinazolinones." This invention presents novel compositions of quinazolinone, characterized by enantiomerically pure compounds represented by a specific formula. His work emphasizes the importance of incorporating detectable amounts of starting materials and reagents used in the synthesis, showcasing his meticulous approach to chemical synthesis.
Career Highlights
Throughout his career, Yiannikourous has worked with prominent companies in the pharmaceutical industry, including Cytokinetics, Inc. and SmithKline Beecham Corporation. His experiences at these organizations have contributed to his profound understanding of drug development processes and innovation in medicinal formulations.
Collaborations
Yiannikourous has collaborated with other talented professionals in his field, including Gustave Bergnes and Edward HyungSuk Ha. Their collective expertise has undoubtedly enriched the development of new methodologies in chemical synthesis and pharmaceutical research.
Conclusion
George Yiannikourous exemplifies the spirit of innovation that drives the pharmaceutical industry forward. His patent on quinazolinone compositions is a testament to his dedication to advancing medicinal chemistry. Through his collaborations and experiences in renowned companies, Yiannikourous continues to pave the way for future breakthroughs in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile